Controls nausea and vomiting associated with certain types of anesthesia and surgery. ANDA 87165, held by Cosette Pharms Nc. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 87165 (Promethegan), held by Cosette Pharms Nc, was first approved by FDA on Aug 14, 1987, with 11 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Promethazine HCl Suppositories, USP are useful for: Perennial and seasonal allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasma. Dermographism. Anaphylactic reactions, as adjunctive therapy to epinephrine and other standard measures, after the acute manifestations have been controlled. Preoperative, postoperative, or obstetric sedation. Prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 14, 1987 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethegan50MG · suppository;rectal | Promethazine Hydrochloride | Rx |
| Sep 7, 2016 | Supplement 24Labeling · Standard review | Approved | None posted |
| Dec 30, 2012 | Supplement 21Labeling | Approved | None posted |
| Dec 30, 2012 | Supplement 19Labeling | Approved | None posted |
| Jun 16, 2004 | Supplement 16Labeling | Approved | None posted |
| Jun 16, 2004 | Supplement 12Labeling | Approved | None posted |
| Nov 4, 2002 | Supplement 11Manufacturing | Approved | None posted |
| Mar 4, 1999 | Supplement 7Manufacturing | Approved | None posted |
| Dec 1, 1993 | Supplement 4Manufacturing | Approved | None posted |
| Nov 8, 1991 | Supplement 3Labeling | Approved | None posted |
| Jul 23, 1991 | Supplement 1Labeling | Approved | None posted |
| May 15, 1991 | Supplement 2Labeling | Approved | None posted |
| Aug 14, 1987 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters